ICD-10 Coding for Swollen Glands(B34.9U, C85.90U, I88.9)

Comprehensive guide on ICD-10 coding for swollen glands, including documentation requirements and clinical validation for lymphadenopathy.

Also known as:
LymphadenopathyLymphadenitisSwollen Lymph Nodes
Related ICD-10 Code Ranges

Complete code families applicable to Swollen Glands

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescription
R59.0Localized enlarged lymph nodes
R59.1Generalized enlarged lymph nodes
R59.9Enlarged lymph nodes, unspecified
L04.9Acute lymphadenitis, unspecified

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information

Essential facts and insights aboutSwollen Glands

Differential Codes

Alternative codes to consider when ruling out similar conditions

Generalized enlarged lymph nodesR59.1
Localized enlarged lymph nodesR59.0
Nonspecific lymphadenitis, unspecifiedI88.9

Documentation & Coding Risks

Avoid these common issues when documenting Swollen Glands.

Failure to document the distribution of lymphadenopathy

Impact

Clinical: May lead to inappropriate treatment decisions., Regulatory: Increases risk of audit and non-compliance., Financial: Potential for reduced reimbursement.

Mitigation

Train staff on the importance of detailed documentation, Use templates to guide thorough documentation

Using R59.9 when more specific codes apply

Impact

Reimbursement: May lead to lower reimbursement due to lack of specificity., Compliance: Increases risk of audit for unspecified coding., Data Quality: Reduces data accuracy for clinical research and reporting.

Mitigation

Query for clarification on whether lymphadenopathy is localized or generalized.

Confusing lymphadenopathy with lymphadenitis

Impact

Reimbursement: Incorrect coding can affect DRG assignment., Compliance: Non-compliance with coding guidelines., Data Quality: Impacts clinical data integrity.

Mitigation

Ensure documentation specifies whether infection is present to use L04 codes.

Use of unspecified codes

Impact

Increased scrutiny on the use of R59.9 for unspecified lymphadenopathy.

Mitigation

Encourage detailed documentation and use of specific codes.

Frequently Asked Questions